Streetbeat News

Analyst Ratings

GRTS

Piper Sandler has maintained an Overweight rating on Gritstone Bio and raised its price target from $6 to $7. This has led to Gritstone Bio's shares trading higher.

Portfolio Pulse from Benzinga Newsdesk

September 28, 2023 | 3:57 pm

WDFC

DA Davidson analyst Linda Bolton Weiser maintains a 'Buy' rating on WD-40 (NASDAQ:WDFC) and raises the price target from $232 to $256.

Portfolio Pulse from Benzinga Newsdesk

September 28, 2023 | 3:53 pm

KWR

RBC Capital analyst Arun Viswanathan has reiterated an Outperform rating on Quaker Houghton (NYSE:KWR) and maintained a price target of $232.

Portfolio Pulse from Benzinga Newsdesk

September 28, 2023 | 3:49 pm

CIEN

T

VZ

Shares of Ciena Corporation (NYSE:CIEN) rose in early trading on Thursday following a positive outlook from Stifel analyst Ruben Roy. Despite a weakened capex environment for telecom and cable operators, Roy believes Ciena will benefit from increasing capex of cloud service providers and the growing complexity of network architecture. He initiated coverage of Ciena with a Buy rating and a price target of $62.

Portfolio Pulse from Priya Nigam

September 28, 2023 | 3:46 pm

BX

A significant bearish stance has been taken on Blackstone (NYSE:BX) with 75% of investors opening trades with bearish expectations. Of the overall spotted trades, 10 are puts, amounting to $670,648 and 2 are calls, amounting to $395,190. Whales have been targeting a price range from $107.0 to $118.0 for Blackstone over the last 3 months. The price of BX is up 0.96% at $107.57. Morgan Stanley downgraded its action to Overweight with a price target of $125.

Portfolio Pulse from Benzinga Insights

September 28, 2023 | 3:46 pm

QCOM

A significant investor has taken a bullish stance on Qualcomm (NASDAQ:QCOM), with 66% of recent trades being bullish and 33% bearish. The total amount for puts is $460,455 and for calls is $193,091. Whales have been targeting a price range from $70.0 to $115.0 for Qualcomm over the last 3 months. Wells Fargo maintains an Underweight rating on Qualcomm with a price target of $100, while Keybanc and Rosenblatt have downgraded their actions to Overweight and Buy with price targets of $145.

Portfolio Pulse from Benzinga Insights

September 28, 2023 | 3:32 pm

JPM

A significant bearish stance has been taken on JPMorgan Chase (NYSE:JPM) as evidenced by unusual options activity. The overall sentiment of these big-money traders is 80% bearish and 20% bullish. The whales have been targeting a price range from $75.0 to $150.0 for JPMorgan Chase over the last 3 months. The price of JPM is up 1.74% at $148.32. Morgan Stanley and Oppenheimer have maintained their Overweight and Outperform ratings on JPMorgan Chase, respectively, while RBC Capital and HSBC have downgraded their actions.

Portfolio Pulse from Benzinga Insights

September 28, 2023 | 3:32 pm

PAYX

RBC Capital analyst Gary Bisbee has reiterated a 'Sector Perform' rating on Paychex (NASDAQ:PAYX) and maintained a price target of $130.

Portfolio Pulse from Benzinga Newsdesk

September 28, 2023 | 3:30 pm

WDAY

RBC Capital analyst Rishi Jaluria has reiterated an Outperform rating on Workday (NASDAQ:WDAY) and maintained a $275 price target.

Portfolio Pulse from Benzinga Newsdesk

September 28, 2023 | 3:26 pm

WVE

Mizuho Securities has issued a 'Buy' rating for Wave Life Sciences, with a price target of $10. The rating comes as Wave Life Sciences enters the obesity market, with its INHBE knockdown leading to a 16% weight loss and significant decrease in fat in 5 weeks.

Portfolio Pulse from Benzinga Newsdesk

September 28, 2023 | 3:22 pm